159 related articles for article (PubMed ID: 2483439)
1. Pharmacological bases for the use of dopamine and related drugs in the treatment of congestive heart failure.
Goldberg LI
J Cardiovasc Pharmacol; 1989; 14 Suppl 8():S21-8. PubMed ID: 2483439
[TBL] [Abstract][Full Text] [Related]
2. The role of dopamine receptors in the treatment of congestive heart failure.
Goldberg LI
J Cardiovasc Pharmacol; 1989; 14 Suppl 5():S19-27. PubMed ID: 2478806
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular and renal action of dopaminergic prodrugs.
Casagrande C; Merlo L; Ferrini R; Miragoli G; Semeraro C
J Cardiovasc Pharmacol; 1989; 14 Suppl 8():S40-59. PubMed ID: 2483441
[TBL] [Abstract][Full Text] [Related]
4. [New inotropic agents in the treatment of congestive heart failure].
Freitas M
Rev Port Cardiol; 1993 Nov; 12 Suppl 4():19-28, 7-8. PubMed ID: 7904458
[TBL] [Abstract][Full Text] [Related]
5. Pharmacotherapeutic profile of ibopamine in heart failure.
Taylor SH
J Cardiovasc Pharmacol; 1989; 14 Suppl 8():S118-23. PubMed ID: 2483437
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological profile of the dopamine (DA) agonists, RS-12254.
Rosenkranz RP; Caroon JM; Clark RD; Eglen RM; Fisher LE; McClelland DL; Michel AD; Muchowski JM; Whiting RL
Proc West Pharmacol Soc; 1991; 34():131-4. PubMed ID: 1686321
[No Abstract] [Full Text] [Related]
7. Dopamine: receptors and clinical applications.
Goldberg LI
Clin Physiol Biochem; 1985; 3(2-3):120-6. PubMed ID: 3159532
[TBL] [Abstract][Full Text] [Related]
8. Effect of therapeutic dopamine administration on myocardial catecholamine and neuropeptide Y concentrations in the failing ventricles of patients with idiopathic dilated cardiomyopathy.
Anderson FL; Port JD; Reid BB; Hanson G; Kralios AC; Hershberger RE; Bristow MR
J Cardiovasc Pharmacol; 1992; 20(5):800-6. PubMed ID: 1280744
[TBL] [Abstract][Full Text] [Related]
9. [Combination of dopamine and dobutamine in the differential therapy of acute and chronic myocardial failure].
Kleinschmidt R; Spannbrucker N; Vogel F
Dtsch Med Wochenschr; 1985 Apr; 110(15):598-603. PubMed ID: 2983969
[No Abstract] [Full Text] [Related]
10. [Clinical efficacy of oral dopaminergic agents: new findings].
Dei Cas L; Metra M; Nodari S; Raccagni D
Cardiologia; 1995 Dec; 40(12 Suppl 1):131-8. PubMed ID: 8998705
[No Abstract] [Full Text] [Related]
11. Long term administration of dopamine: is there a development of tolerance?
Braun GG; Bahlmann F; Brandl M; Knoll R
Prog Clin Biol Res; 1989; 308():1097-9. PubMed ID: 2550954
[No Abstract] [Full Text] [Related]
12. Clinical use of dopamine receptor agonists.
Murphy MB
Proc West Pharmacol Soc; 1990; 33():31-5. PubMed ID: 1980363
[TBL] [Abstract][Full Text] [Related]
13. [Dopamine and dopaminergic drugs as therapeutic agents in heart failure].
van Zwieten PA
Ned Tijdschr Geneeskd; 1990 Nov; 134(47):2281-4. PubMed ID: 1979426
[No Abstract] [Full Text] [Related]
14. Role of dopamine receptors and the utility of dopamine agonists in heart failure.
Rajfer SI; Davis FR
Circulation; 1990 Aug; 82(2 Suppl):I97-102. PubMed ID: 1973645
[TBL] [Abstract][Full Text] [Related]
15. [Mechanism of action of ibopamine: pharmacological effects of epinine and other metabolites].
Ferrini R; Merlo L; Miragoli G
Cardiologia; 1988 Jan; 33(1):49-53. PubMed ID: 2835159
[No Abstract] [Full Text] [Related]
16. Development of dopaminergic drugs for the chronic treatment of congestive heart failure.
Casagrande C; Merlo L; La Regina A
J Auton Pharmacol; 1990; 10 Suppl 1():s85-93. PubMed ID: 1983011
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular and renal actions of dopamine: potential clinical applications.
Goldberg LI
Pharmacol Rev; 1972 Mar; 24(1):1-29. PubMed ID: 4554480
[No Abstract] [Full Text] [Related]
18. Clinical pharmacology of inodilators.
Dei Cas L; Metra M; Visioli O
J Cardiovasc Pharmacol; 1989; 14 Suppl 8():S60-71. PubMed ID: 2483442
[TBL] [Abstract][Full Text] [Related]
19. Newer catecholamines for treatment of heart failure and shock: an update on dopamine and a first look at dobutamine.
Goldberg LI; Hsieh YY; Resnekov L
Prog Cardiovasc Dis; 1977; 19(4):327-40. PubMed ID: 12536
[No Abstract] [Full Text] [Related]
20. [The dobutamine-dopamine combination versus amrinone in congestive heart failure with a marked edematogenic sign complicated by functional kidney failure. A comparison between 2 different models of inotropic stimulation and diuresis potentiation].
De Vecchis R; Pucciarelli G; Nocerino L; Cocozza M; Setaro A; Torre G; Imperatore F
Minerva Cardioangiol; 1998 May; 46(5):163-74. PubMed ID: 9842199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
